Methylprednisolone hemisuccinate

1 1

Selleck Chemicals

S6588-25MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

Methylprednisolone hemisuccinate is a ligand linked to Hormone Signaling and related pathway-oriented research. In practice, this places the compound in experiments that measure ligand-dependent transcriptional programs and endocrine regulation in endocrinology models.

The pathway annotation connects Methylprednisolone hemisuccinate to Hormone Signaling, supporting experiments that monitor ligand-dependent transcriptional programs and endocrine regulation across biochemical, cellular, or phenotypic assay formats. This context is compatible with hormone-response, reporter, and receptor assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to Hormone Signaling
  • Ligand-binding and signaling assays
  • Phenotypic profiling in endocrinology models
  • Combination studies with orthogonal perturbagens

Overall, Methylprednisolone hemisuccinate is well suited to pathway-oriented studies that need a defined compound input for Hormone Signaling readouts in endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
Hormone Signaling
Research Area:
Endocrinology
CAS No.:
2921-57-5
Molecular Weight:
474.54
Formula:
C₂₆H₃₄O₈
SMILES:
CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.